MediQuest Announces Sale of Late Stage Onychomycosis Program to EFFELL…
MediQuest Therapeutics announces the sale of late stage Onychomycosis/Onycholysis programs to EFFELL LLC, the first in a series of asset sales.
(PRWeb September 19, 2012)
Read the full story at http://www.prweb.com/releases/2012/9/prweb9911525.htmClick here for reuse options!
Copyright 2012 Biotechblog
Comments are closed.